Fibroblast activation protein constitutes a novel target of chimeric antigen receptor T‐cell therapy in solid tumors

Documenti analoghi

• Fat and proteolysis due to methionine, tryptophan, and niacin deficiency leads to alterations in gut microbiota and immune modulation in inflammatory bowel disease
  di: Tomoaki Hara, et al.
  Pubblicazione: (2024)
• RNA methylation in inflammatory bowel disease
  di: Yuki Ozato, et al.
  Pubblicazione: (2024)
• Recent Findings in N6‐Methyladenosine Modification and Significance in Pancreatic Cancer
  di: Tomoaki Hara, et al.
  Pubblicazione: (2025)
• Advances in research on factors affecting chimeric antigen receptor T‐cell efficacy
  di: Delian Zhou, et al.
  Pubblicazione: (2024)
• Indicators describing the tumor lesion aggregation and dissemination and their impact on the prognosis of patients with diffuse large B cell lymphoma receiving chimeric antigen receptor T cell therapy
  di: Xiuyong Dang, et al.
  Pubblicazione: (2024)